JP2023515101A5 - - Google Patents
Info
- Publication number
- JP2023515101A5 JP2023515101A5 JP2022550119A JP2022550119A JP2023515101A5 JP 2023515101 A5 JP2023515101 A5 JP 2023515101A5 JP 2022550119 A JP2022550119 A JP 2022550119A JP 2022550119 A JP2022550119 A JP 2022550119A JP 2023515101 A5 JP2023515101 A5 JP 2023515101A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025078577A JP7808226B2 (ja) | 2020-02-21 | 2025-05-09 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062980143P | 2020-02-21 | 2020-02-21 | |
| US62/980,143 | 2020-02-21 | ||
| PCT/US2021/019113 WO2021168446A1 (en) | 2020-02-21 | 2021-02-22 | Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025078577A Division JP7808226B2 (ja) | 2020-02-21 | 2025-05-09 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023515101A JP2023515101A (ja) | 2023-04-12 |
| JP2023515101A5 true JP2023515101A5 (https=) | 2024-09-18 |
| JPWO2021168446A5 JPWO2021168446A5 (https=) | 2024-09-18 |
Family
ID=77391353
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550119A Withdrawn JP2023515101A (ja) | 2020-02-21 | 2021-02-22 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
| JP2025078577A Active JP7808226B2 (ja) | 2020-02-21 | 2025-05-09 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025078577A Active JP7808226B2 (ja) | 2020-02-21 | 2025-05-09 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240018146A1 (https=) |
| EP (1) | EP4106874A4 (https=) |
| JP (2) | JP2023515101A (https=) |
| KR (1) | KR20220158290A (https=) |
| CN (1) | CN115515682B (https=) |
| AU (1) | AU2021222053A1 (https=) |
| BR (1) | BR112022016614A2 (https=) |
| CA (1) | CA3168531A1 (https=) |
| CO (1) | CO2022013603A2 (https=) |
| CR (1) | CR20220476A (https=) |
| EC (1) | ECSP22074210A (https=) |
| IL (1) | IL295681B1 (https=) |
| MX (1) | MX2022010309A (https=) |
| PH (1) | PH12022552518A1 (https=) |
| WO (1) | WO2021168446A1 (https=) |
| ZA (1) | ZA202210409B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021012129A (es) * | 2019-04-03 | 2022-01-31 | Mitokinin Inc | Composiciones y método para utilizarlas para el tratamiento de enfermedades neurodegenerativas y mitocondriales. |
| CN119752781B (zh) * | 2025-03-04 | 2025-07-01 | 中国农业大学 | 缓解成熟卵子老化的组合物、培养液、产品及方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9604361D0 (en) * | 1996-02-29 | 1996-05-01 | Pharmacia Spa | 4-Substituted pyrrolopyrimidine compounds as tyrosine kinase inhibitors |
| TW200508224A (en) * | 2003-02-12 | 2005-03-01 | Bristol Myers Squibb Co | Cyclic derivatives as modulators of chemokine receptor activity |
| EA024006B1 (ru) * | 2006-02-02 | 2016-08-31 | Миллениум Фармасьютикалз, Инк. | Ингибиторы е1 активирующих ферментов |
| EP2061772A4 (en) * | 2006-09-11 | 2011-06-29 | Curis Inc | MULTIFUNCTIONAL SMALL MOLECULES AS PROLIFERATION-ACTIVE ACTIVE SUBSTANCES |
| BRPI0918502A2 (pt) * | 2008-09-02 | 2015-12-01 | Sanofi Aventis | aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos |
| WO2014124458A1 (en) * | 2013-02-11 | 2014-08-14 | The Regents Of The University Of California | Compositions and methods for treating neurodegenerative diseases |
| EP3641545A4 (en) * | 2017-06-21 | 2021-02-24 | Mitokinin, Inc. | COMPOSITIONS AND METHODS USING THEM FOR THE TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE |
-
2021
- 2021-02-22 MX MX2022010309A patent/MX2022010309A/es unknown
- 2021-02-22 CR CR20220476A patent/CR20220476A/es unknown
- 2021-02-22 US US17/801,450 patent/US20240018146A1/en active Pending
- 2021-02-22 KR KR1020227032526A patent/KR20220158290A/ko active Pending
- 2021-02-22 AU AU2021222053A patent/AU2021222053A1/en active Pending
- 2021-02-22 WO PCT/US2021/019113 patent/WO2021168446A1/en not_active Ceased
- 2021-02-22 CN CN202180025593.5A patent/CN115515682B/zh active Active
- 2021-02-22 IL IL295681A patent/IL295681B1/en unknown
- 2021-02-22 EP EP21757063.9A patent/EP4106874A4/en active Pending
- 2021-02-22 JP JP2022550119A patent/JP2023515101A/ja not_active Withdrawn
- 2021-02-22 CA CA3168531A patent/CA3168531A1/en active Pending
- 2021-02-22 PH PH1/2022/552518A patent/PH12022552518A1/en unknown
- 2021-02-22 BR BR112022016614A patent/BR112022016614A2/pt unknown
-
2022
- 2022-09-20 ZA ZA2022/10409A patent/ZA202210409B/en unknown
- 2022-09-21 CO CONC2022/0013603A patent/CO2022013603A2/es unknown
- 2022-09-21 EC ECSENADI202274210A patent/ECSP22074210A/es unknown
-
2025
- 2025-05-09 JP JP2025078577A patent/JP7808226B2/ja active Active